Gallipoli Medical Research Foundation

Greenslopes, Queensland QLD 4120

2 studies enrolling now · 9 studies all time

What they study most

Acral Melanoma, Advanced Solid Tumor, Basal Cell Carcinoma, Bladder Cancer, Breast Cancer, Cancer With A High Tumor Mutational Burden, Castration-resistant Prostate Cancer, Cervical Cancer, Cervical Cancers, Chronic Hepatitis B, Chronic Hepatitis C, Clear Cell Renal Cell Carcinoma

Studies at this site

• Neoadjuvant Darovasertib in Primary Uveal Melanoma — Recruiting now
• A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments — Recruiting now
• A Beta-only IL-2 ImmunoTherapY Study — Recruiting now
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies — Completed
• A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection — Stopped early
• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed